Optic neuritis (ON) patients can be divided into two groups based on the presence or absence of asymptomatic demyelinating lesions (ADLs) on brain MRI. The presence of ADLs is associated with an increased risk of progression to clinically definite multiple sclerosis (CDMS). The clinical data and brain MRI of 110 patients with acute unilateral ON were analyzed. Patients with ADLs had a significantly higher incidence of ON in spring months as compared with patients with no ADLs (p ¼ 0.0024). Increased incidence of ON in spring months was seen in patients with ADLs whether or not they were diagnosed with CDMS on follow-up.
Introduction
Recent studies have elucidated the remarkable prognostic value of MRI in patients presenting with their first clinical neurological event. The risk of progression to clinically definite multiple sclerosis (CDMS) was increased from 11% in patients without asymptomatic demyelinating lesions (ADLs) to more than 80% in patients with two or more ADLs on brain MRI based on a 10-year follow-up study. 1 This trend has been confirmed in other publications. 2, 3 Even one ADL seen on brain MRI at the time of first clinical attack places the patient into a high-risk group. 3 The etiology of multiple sclerosis (MS) remains unknown. Genetic markers as well as environmental factors, such as viral infection and exposure to sunlight/vitamin D, are suspected to be risk factors. 4 A seasonal pattern for both monosymptomatic optic neuritis (ON) and MS onset in the Northern Hemisphere has been clearly established with the highest incidence of both in spring (March-May) and the lowest in winter (for a review, see Jin et al. 5 ). The opposite trend was reported in the Southern Hemisphere. 4 We hypothesized that ON which results from a generalized demyelinating disease process is pathophysiologically different from isolated ON which has no tendency to cause demyelinating lesions in other parts of the central nervous system. As the presence of ADLs on brain MRI at ON onset may serve as a marker of previous clinical or subclinical demyelinating events, we retrospectively evaluated a possible link between the presence of ADLs in brain and the seasonal pattern of ON.
Methods

Study population
We used all of the electronic records available prior to May 2007 from the neuro-ophthalmology clinic of the New Jersey Neuroscience Institute to find patients with the new onset of mono-symptomatic unilateral ON. The search revealed 132 patients; 22 patients were excluded from further study for the following reasons:
(1) Prior history or clinical or laboratory evidence consistent with a disease which could cause ON, e.g., Lyme (n ¼ 5), lupus (n ¼ 1), HIV (n ¼ 1).
(2) The absence of brain MRI in clinical records (n ¼ 15).
The remaining population of 110 patients (81 females and 29 males) had an average age (mean AE SEM) of 35.4 AE 0.9 years old. Their records were analyzed to compare brain MRI characteristics, clinical history and exam data. The patients were divided into four subgroups based on the season during which ON was diagnosed: winter (December to February), spring (March to May), summer (June to August) and fall (September to November).
Brain MRI
All 110 patients had a brain MRI study ordered at the time of their first visit. Most studies utilized 1.5-Tesla MRI machines and all had T1WI and T2WI sequences. The patients were divided into ADL-negative and ADL-positive based on the presence of ADLs reported by the neuro-radiologist.
Statistical methods
The figures were drawn and statistical analysis was performed with a GraphPad package from GraphPad Software, Inc., La Jolla, CA. The Fisher's exact test using two-tailed p-values was utilized.
Results
Out of 110 ON patients, 72 patients were ADL-positive and 38 ON patients were ADL-negative. The incidence of ON was not evenly distributed throughout the year. A higher proportion of patients with ADL had the onset of symptoms in spring (41.7%) as compared with 13.2% ON patients with ADL-negative brain MRI, p ¼ 0.0024 based on Fisher's exact test ( Figure 1 and Table 1 ) There was no statistical difference in ON incidence between those two groups in any other season. Neither the number of periventricular lesions nor the number of infratentorial lesions on initial MRI varied significantly with the season of presentation (not shown). The majority (81%) of brain MRIs performed with and without IV contrast had no active (contrast-enhancing) ADLs. Comparing ON patients with and without ADL, there was no significant difference in mean age at onset of symptoms (36.0 AE 1.1 versus 34.1 AE 1.5, p ¼ 0.3023 based on a t-test) or in the proportion of females to males (55 females and 17 males versus 26 females and 12 males, p ¼ 0.3733 based on Fisher's exact test). Prior to or at the time ON attack, CDMS, as per Poser's criteria, 6 was diagnosed in two patients (one ADL-positive and one ADL-negative). After the ON attack, the Table 1 . Increased incidence of optic neuritis (ON) in spring months in patients with asymptomatic demyelinating lesions (ADLs). The incidence of ON is shown for patients with and without ADLs on brain MRI (ADL-positive and ADL-negative, respectively) There was no significant statistical difference among above two groups in other seasons (winter, summer, fall).
patients were followed for (mean AE SD) 22.8 AE 27.6 months and CDMS was diagnosed in 26 patients (24 ADL-positive and 2 ADL-negative). As expected, significantly more patients were diagnosed with CDMS among patients with ADLs than among patients without ADLs on brain MRI (24 of 72 versus 2 of 38, p ¼ 0.0074 based on Fisher's exact test). The increased ON incidence in spring months as compared with non-spring months was seen in both ADL-positive patients who were diagnosed with CDMS (not significant presumably due to a small number of patients in the group) and ADL-positive non-CDMS patients (p ¼ 0.0075) as compared with ADL-negative patients ( Table 1 ).
Discussion
The published MRI studies to date have found no significant seasonal differences in MRI activity in CDMS. [7] [8] [9] This lack of variability could be partially due to the effect of treatment. A recent analysis of serial bi-weekly MRI involving a large group of more than 40 non-treated MS patients in New England revealed a statistically significant seasonal variation in the incidence of new T2 lesions. The peak of disease activity shown on MRI was noted in spring-summer months with the minimal activity seen in the September-February period (D. Meier, submitted for publication, October 2009). None of these MRI studies included new lesions in the optic nerve due to technical limitations. We report for the first time that patients with ADL have increased incidence of ON in spring months as compared with patients with no ADL. Our findings add to the mounting evidence suggesting that different environmental factors may trigger the demyelinating process in the optic nerve of patients with recurrent demyelinating disease as compared with patients with monophasic demyelinating attack of ON. Future studies may help to elucidate the exact nature of the above factors and lead to targets for new MS treatment.
